An Outline of the Swiss Biotech Industry and its Management of Financial Statement Informativeness

Biotech companies face industry-specific challenges and risks. They are looking for customized services fitting their specific needs, including audit services. Audit firms need to understand the business and the risks related to this industry to be able to develop and apply the best tailored solutions.

Kämpf, Michael & Balsiger, Micha, 2020

Art der Arbeit Bachelor Thesis
Auftraggebende KPMG
Betreuende Dozierende Waterstraat, Silke
Keywords Biotechnology, Switzerland, Risks, Financial Statement, Intellectual Capital
Views: 36 - Downloads: 10
In order to establish an audit program tailored to the industry specifics, the industry itself must be understood from the bottom to the top. Further, besides the descriptive industry characteristics, the specificities of the financial statements and their informativeness have to be analyzed and interpreted. This has not yet been done in the Swiss biotechnology environment and is therefore a requirement for a future biotech audit program.
In a literature review, the biotech industry was extensively outlined. Further, the authors focused on gathering insights about industry-specific risks. A list of all Swiss biotech startups with information about their fields of activity, location, age, management and size was compiled as a base to gather further primary data about the industry, e.g., in form of a survey. Further, an empirical analysis was conducted with a sample of listed Swiss biotech companies to examine the relationship between intellectual capital disclosure and financial statement informativeness.
The literature review covers important, industry-specific knowledge such as life-cycle and business model specificities and the role of strategic alliances in the Swiss biotechnology industry. Several operational and financial risks are explained and their importance for the biotechnology industry was outlined. The gathered data about Swiss biotech companies provides various characteristics of the companies and provides a resource to address companies for further research. The thesis summarizes the literature on financial statement informativeness and voluntary intellectual capital disclosure of Swiss biotechnology companies. A statistical analysis suggests that companies with a lower financial statement informativeness tend to disclose more information about their intellectual capital.
Studiengang: Business Administration International Management (Bachelor)
Vertraulichkeit: öffentlich
Art der Arbeit
Bachelor Thesis
Auftraggebende
KPMG, Basel
Autorinnen und Autoren
Kämpf, Michael & Balsiger, Micha
Betreuende Dozierende
Waterstraat, Silke
Publikationsjahr
2020
Sprache der Arbeit
Englisch
Vertraulichkeit
öffentlich
Studiengang
Business Administration International Management (Bachelor)
Standort Studiengang
Olten
Keywords
Biotechnology, Switzerland, Risks, Financial Statement, Intellectual Capital